Starton Therapeutics Strengthens Clinical Development Strategy Following Successful Scientific Advisory Board Meeting at ASCO 2024
August 22, 2024 08:00 ET
|
Starton Therapeutics Inc.
Scientific advisory board highly encouraged by STAR-LLD early Phase 1b data in multiple myelomaStrengthened the clinical strategy to focus on addressing major unmet medical needs and pursuing...